Brian McNamara appointed CEO designate of new independent consumer health care company
LONDON — Brian McNamara has been named CEO designate of the new, independent consumer health care company that will be spun off from GSK in 2022. As set out at GSK’s Investor Update on 23 June 2021, subject to approval from shareholders, the separation of Consumer Health care will be by way of a demerger